Morning Headlines 2/13/17

Cerner (CERN) Q4 2016 Results – Earnings Call Transcript

In its Q4 earnings call, Cerner President Zane Burke reports bookings were up seven percent, compared to 28 percent growth in 2015, calling the results “solid, particularly when you consider the headwinds created by declines in tech resale.”

Work, Health, And Insurance: A Shifting Landscape For Employers And Workers Alike

A Health Affairs study examines the relationship between work, health, and health insurance given the changing demographic and employment conditions in the US.

Bias in the ER

Michael Lewis, author of “Moneyball” and “The Big Short,” argues in his new book that doctors are just as likely to ignore statistics, often treating a statistically unlikely diagnosis that fits the observable symptoms. He quotes a Canadian trauma center doctor who explains, “You need to be so careful when there is one simple diagnosis that instantly pops into your mind that beautifully explains everything all at once.”

Marathon Pharmaceuticals to Charge $89,000 for Muscular Dystrophy Drug After 70-Fold Increase

Marathon Pharmaceuticals intends to bring a drug used to treat muscular dystrophy to the US for $89,000 per year, while it is available in Europe for just $1,600 per year.